title: Molecular genetics of brain tumors.
abstract: As many as 40000 patients are newly diagnosed each year as having brain tumors. About half of these are metastatic foci of tumors originating outside the central nervous system, while the other half are primary tumors of central nervous system tissues. These are a diverse group of neoplasms. Currently, primary brain tumors are classified in a manner that reflects their histological appearance and location. The identification of cancer as a disorder of genes, however, has opened the possibility of classifying tumors according to the genetic alterations that underlie their pathogenesis and that regulate their malignant behavior. Two major classes of genes critical for the development of all types of cancer, including brain tumors, are now recognized: tumor suppressor genes, which encode genes that function to inhibit cell proliferation and tumor development, and oncogenes, which encode proteins that stimulate proliferation and mediate biological activities important for invasion, neoangiogenesis, immune escape, and other characteristics of malignancy. While in most cases the specific pathways regulating tumor characteristics such as tumor neoangiogenesis and tissue invasion remain to be defined, recognition of the genetic changes characteristic of individual tumor types should provide opportunities to develop more effective, less toxic therapies.
authors: Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco 94143-0520, USA.
authors: J R
authors: JR
authors: Hill
authors: N
authors: N
authors: Kuriyama
authors: H
authors: H
authors: Kuriyama
authors: M A
authors: MA
authors: Israel
mesh_terms: D001932:Brain Neoplasms / Q000145:classification / Q000235:genetics* / Q000473:pathology; D002471:Cell Transformation, Neoplastic; D016147:Genes, Tumor Suppressor / Q000235:genetics*; D006801:Humans; D008579:Meningioma / Q000145:classification / Q000235:genetics / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000235:genetics; D009367:Neoplasm Staging / Q000379:methods; D018242:Neuroectodermal Tumors, Primitive / Q000145:classification / Q000235:genetics / Q000473:pathology; D009837:Oligodendroglioma / Q000145:classification / Q000235:genetics / Q000473:pathology; D009857:Oncogenes / Q000235:genetics*